NFKB1 and diabetes mellitus: Our data suggest that HspB4/αA-crystallin can also dampen the inflammatory mediator induction in the more chronic and “diabetic-like condition” controlled by NF-kB, a key modulator of the expression of cytokines and inflammatory molecules associated with diabetes complications [65,66].